<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3852805/" ref="ordinalpos=887&amp;ncbi_uid=5602092&amp;link_uid=PMC3852805" image-link="/pmc/articles/PMC3852805/figure/fig2/" class="imagepopup">Figure 2.  From: Prooxidant Mechanisms in Iron Overload Cardiomyopathy. </a></div><br /><div class="p4l_captionBody">Adiponectin ameliorates cardiac inflammation in IOC through the PPARα-PGC1-dependent signaling pathway. The schematic diagram showing that adiponectin exerts its beneficial effects in cardiomyocytes through the PPARα-dependent HO-1 signaling pathway and requires PPARα-PGC-1 interaction. The adiponectin-AdipoR2-PPARα signaling may be the major pathway in exerting anti-inflammatory and antioxidative stress effects that ameliorate iron-overload cardiac dysfunction.</div></div>